Two are still open: TRIUMPH-7 (NCT07035093), for obesity or overweight with chronic low back pain, and the Phase 3 multi-agent MASLD master protocol (NCT07165028), which studies several drugs rather than retatrutide alone
doi:10.1038/s41598-020-74022-y Lozic M, Stambolija V, Krezic I, et al
When comparing providers, calculate what you'll actually pay each month, including every fee, at the dose you expect to reach
For injectable GLP-1 medications: Timing requirements : For once-weekly injections (semaglutide [Ozempic, Wegovy], dulaglutide [Trulicity], exenatide extended-release), administration can occur at any time of day, with or without food
GLP-1 also slows down the rate at which the stomach empties, which helps control appetite and food intake